Top Markets
Coin of the day
MicroPort NeuroTech Limited MicroPort NeuroTech Limited

MicroPort NeuroTech Limited

2172
Classement en actions #11874
Established in 2004 and headquartered in Shanghai, People's Republic of China,... Established in 2004 and headquartered in Shanghai, People's Republic of China, MicroPort NeuroTech Limited is dedicated to the research, development, manufacturing, and global commercialization of neuro-interventional medical devices. The company's diverse product portfolio addresses various cerebrovascular conditions. For treating hemorrhagic stroke, it offers the NUMEN coil embolization system, the NUMEN FR coil detachment system, the Tubridge flow-diverting stent, the Willis intracranial stent graft system, and the Rebridge intracranial visualized stent. Additionally, MicroPort NeuroTech supplies the APOLLO intracranial arterial stent system for intracranial atherosclerotic disease, as well as the Bridge rapamycin target eluting vertebral artery stent system specifically designed for cerebral atherosclerotic stenosis. To address acute ischemic stroke, the company provides the Neurohawk stent thrombectomy device and the Tigertriever adjustable stent retriever.
Prix de l'action
$1.04
Capitalisation boursière
$603.62M
Changement (1 jour)
-2.52%
Changement (1 an)
-38.05%
Pays
CN
Échange MicroPort NeuroTech Limited (2172)

Catégorie

EPS pour MicroPort NeuroTech Limited (2172)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de MicroPort NeuroTech Limited, l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de MicroPort NeuroTech Limited de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$3.11 -
US
$9.73 -
US
$3.59 -
IE
$2.48 -
US
- -
DE